S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
$2.72
+10.1%
$4.06
$2.38
$62.30
$716.12M1.6215.17 million shs30.68 million shs
AstraZeneca PLC stock logo
AZN
AstraZeneca
$68.27
-0.7%
$65.96
$60.47
$76.56
$211.66B0.56.22 million shs3.82 million shs
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.64
-1.2%
$0.75
$0.61
$4.05
$10.88M5.97265,019 shs56,838 shs
GameStop Corp. stock logo
GME
GameStop
$10.37
+3.1%
$13.51
$9.95
$27.65
$3.17B-0.453.86 million shs4.00 million shs
GSK plc stock logo
GSK
GSK
$39.95
-1.4%
$42.07
$33.33
$43.84
$82.79B0.643.52 million shs2.42 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.69
-0.8%
$27.27
$25.61
$41.33
$145.47B0.6142.54 million shs28.61 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
-6.79%-16.27%-44.37%-41.40%-94.33%
AstraZeneca PLC stock logo
AZN
AstraZeneca
-0.29%+1.52%+3.65%+2.17%-6.95%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-6.41%-5.40%-10.82%-41.07%-79.31%
GameStop Corp. stock logo
GME
GameStop
-6.50%-7.19%-29.28%-27.99%-55.16%
GSK plc stock logo
GSK
GSK
-0.39%-0.87%-4.01%+1.53%+7.23%
Pfizer Inc. stock logo
PFE
Pfizer
+0.15%-2.56%-7.30%-8.51%-37.12%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
2.2976 of 5 stars
2.72.00.03.41.10.00.6
AstraZeneca PLC stock logo
AZN
AstraZeneca
3.3243 of 5 stars
2.35.01.70.02.70.03.1
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.8463 of 5 stars
0.03.00.00.01.92.51.3
GameStop Corp. stock logo
GME
GameStop
1.1813 of 5 stars
0.50.00.02.12.32.51.9
GSK plc stock logo
GSK
GSK
2.0252 of 5 stars
0.03.03.30.01.40.02.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9912 of 5 stars
3.25.04.24.82.61.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
1.40
Strong Sell$6.35133.46% Upside
AstraZeneca PLC stock logo
AZN
AstraZeneca
2.33
Hold$80.0017.18% Upside
Cosmos Health Inc. stock logo
COSM
Cosmos Health
3.00
BuyN/AN/A
GameStop Corp. stock logo
GME
GameStop
1.00
Sell$5.60-46.00% Downside
GSK plc stock logo
GSK
GSK
2.40
HoldN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
2.35
Hold$36.8843.54% Upside

Current Analyst Ratings

Latest COSM, GME, AMC, PFE, GSK, and AZN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Hold
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
3/27/2024
GameStop Corp. stock logo
GME
GameStop
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$6.00 ➝ $5.60
3/22/2024
Pfizer Inc. stock logo
PFE
Pfizer
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/4/2024
GSK plc stock logo
GSK
GSK
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
2/29/2024
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral$12.00 ➝ $8.00
2/23/2024
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$6.00
2/23/2024
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
2/20/2024
Cosmos Health Inc. stock logo
COSM
Cosmos Health
Taglich Brothers
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSpeculative Buy
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
$4.81B0.15N/AN/A($7.09) per share-0.38
AstraZeneca PLC stock logo
AZN
AstraZeneca
$45.81B4.62$5.35 per share12.77$12.63 per share5.41
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$50.35M0.22N/AN/A$3.71 per share0.17
GameStop Corp. stock logo
GME
GameStop
$5.27B0.60$0.23 per share44.71$4.38 per share2.37
GSK plc stock logo
GSK
GSK
$37.71B2.20$5.10 per share7.84$7.74 per share5.16
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.49$2.96 per share8.69$15.81 per share1.62

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
-$396.60M-$2.35N/AN/AN/A-8.24%N/A-3.61%5/3/2024 (Estimated)
AstraZeneca PLC stock logo
AZN
AstraZeneca
$5.96B$1.9235.5614.651.2613.00%30.19%11.57%4/25/2024 (Confirmed)
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$13.83MN/A0.00N/AN/A-31.48%-28.54%-17.69%5/21/2024 (Estimated)
GameStop Corp. stock logo
GME
GameStop
$6.70M$0.02518.76103.70N/A0.13%1.35%0.59%6/5/2024 (Estimated)
GSK plc stock logo
GSK
GSK
$6.13B$3.0113.279.001.8616.24%51.45%10.57%5/1/2024 (Confirmed)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3671.369.311.163.62%10.88%4.91%5/1/2024 (Confirmed)

Latest COSM, GME, AMC, PFE, GSK, and AZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
GSK plc stock logo
GSK
GSK
$0.95N/A-$0.95N/AN/AN/A
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/25/2024N/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
$0.97N/A-$0.97N/AN/AN/A
3/26/2024Q4 23
GameStop Corp. stock logo
GME
GameStop
$0.29$0.22-$0.07$0.23$2.05 billion$1.79 billion  
2/28/2024Q4 2023
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
-$0.70-$0.54+$0.16-$0.25$1.06 billion$1.10 billion
2/8/202412/31/2023
AstraZeneca PLC stock logo
AZN
AstraZeneca
$0.74$0.73-$0.01$1.15$12.07 billion$12.02 billion    
1/31/2024Q4 2023
GSK plc stock logo
GSK
GSK
$0.76$0.72-$0.04$1.23$9.79 billion$10.00 billion
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
N/AN/AN/AN/AN/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
$1.932.83%+1.18%100.52%1 Years
Cosmos Health Inc. stock logo
COSM
Cosmos Health
N/AN/AN/AN/AN/A
GameStop Corp. stock logo
GME
GameStop
N/AN/AN/AN/AN/A
GSK plc stock logo
GSK
GSK
$1.593.98%-18.20%52.82%1 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.54%+2.57%466.67%15 Years

Latest COSM, GME, AMC, PFE, GSK, and AZN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
GSK plc stock logo
GSK
GSK
quarterly$0.35643.4%2/22/20242/23/20244/11/2024
2/8/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Semi-Annual$0.96502.3%2/22/20242/23/20243/25/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
N/A
0.74
0.74
AstraZeneca PLC stock logo
AZN
AstraZeneca
0.57
0.82
0.64
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.08
2.06
1.79
GameStop Corp. stock logo
GME
GameStop
0.01
2.11
1.44
GSK plc stock logo
GSK
GSK
1.19
0.88
0.62
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
28.80%
AstraZeneca PLC stock logo
AZN
AstraZeneca
20.35%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
12.61%
GameStop Corp. stock logo
GME
GameStop
29.21%
GSK plc stock logo
GSK
GSK
15.74%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
0.28%
AstraZeneca PLC stock logo
AZN
AstraZeneca
N/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
18.74%
GameStop Corp. stock logo
GME
GameStop
12.64%
GSK plc stock logo
GSK
GSK
10.00%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
33,812263.28 million262.54 millionOptionable
AstraZeneca PLC stock logo
AZN
AstraZeneca
89,9003.10 billionN/AOptionable
Cosmos Health Inc. stock logo
COSM
Cosmos Health
10216.93 million13.76 millionOptionable
GameStop Corp. stock logo
GME
GameStop
8,000305.87 million267.21 millionOptionable
GSK plc stock logo
GSK
GSK
70,2002.07 billion1.87 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

COSM, GME, AMC, PFE, GSK, and AZN Headlines

SourceHeadline
Pfizers Doldrums, Just A Bad Case Of COVID-19?Pfizer's Doldrums, Just A Bad Case Of COVID-19?
seekingalpha.com - April 16 at 2:34 PM
Pfizer (NYSE:PFE) Stock Price Down 0.2%Pfizer (NYSE:PFE) Stock Price Down 0.2%
marketbeat.com - April 16 at 2:02 PM
SVB Wealth LLC Sells 35,727 Shares of Pfizer Inc. (NYSE:PFE)SVB Wealth LLC Sells 35,727 Shares of Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 16 at 11:27 AM
Pfizers (PFE) Overweight Rating Reaffirmed at Cantor FitzgeraldPfizer's (PFE) Overweight Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - April 16 at 4:26 AM
Why the Market Dipped But Pfizer (PFE) Gained TodayWhy the Market Dipped But Pfizer (PFE) Gained Today
zacks.com - April 15 at 6:51 PM
Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A TalkPfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk
seekingalpha.com - April 15 at 5:39 PM
Pfizer (NYSE:PFE) Trading Up 0.7%Pfizer (NYSE:PFE) Trading Up 0.7%
marketbeat.com - April 15 at 3:37 PM
A Closer Look at Pfizers Options Market DynamicsA Closer Look at Pfizer's Options Market Dynamics
benzinga.com - April 15 at 12:38 PM
Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 15 at 11:27 AM
Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)
marketbeat.com - April 15 at 11:21 AM
Is Pfizer Stock a Buy?Is Pfizer Stock a Buy?
fool.com - April 15 at 8:45 AM
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis marketPfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
biopharma-reporter.com - April 15 at 7:37 AM
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
fool.com - April 15 at 4:53 AM
Conning Inc. Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)Conning Inc. Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 14 at 3:45 PM
Pfizer (NYSE:PFE) Trading Down 0.8%Pfizer (NYSE:PFE) Trading Down 0.8%
americanbankingnews.com - April 14 at 3:12 AM
Lecap Asset Management Ltd. Invests $1.32 Million in Pfizer Inc. (NYSE:PFE)Lecap Asset Management Ltd. Invests $1.32 Million in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 13 at 8:17 PM
Pfizer wins pause on Modernas COVID-19 patent lawsuitPfizer wins pause on Moderna's COVID-19 patent lawsuit
reuters.com - April 13 at 7:22 PM
The Smartest Dividend Stocks to Buy With $400 Right NowThe Smartest Dividend Stocks to Buy With $400 Right Now
fool.com - April 13 at 5:47 AM
Pfizer Inc. (NYSE:PFE) to Post Q1 2025 Earnings of $0.59 Per Share, Zacks Research ForecastsPfizer Inc. (NYSE:PFE) to Post Q1 2025 Earnings of $0.59 Per Share, Zacks Research Forecasts
americanbankingnews.com - April 13 at 3:08 AM
Pfizer Inc. (NYSE:PFE) Stock Position Lessened by Xcel Wealth Management LLCPfizer Inc. (NYSE:PFE) Stock Position Lessened by Xcel Wealth Management LLC
marketbeat.com - April 12 at 7:27 PM
Pfizers Innovative Drug Pipeline Provides Ample Reason To Buy It HerePfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here
seekingalpha.com - April 12 at 7:27 PM
Big Pharma: Investment BedrockBig Pharma: Investment Bedrock
finance.yahoo.com - April 12 at 7:27 PM
Pfizer’s 15-month fall: Will the stock ever recover?Pfizer’s 15-month fall: Will the stock ever recover?
kalkinemedia.com - April 12 at 2:26 PM
Pfizer (NYSE:PFE) Stock Price Down 0.8%Pfizer (NYSE:PFE) Stock Price Down 0.8%
marketbeat.com - April 12 at 2:02 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AMC Entertainment logo

AMC Entertainment

NYSE:AMC
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. It owns, operates, or has interests in theatres in the United States and Europe. The company was founded in 1920 and is headquartered in Leawood, Kansas.
AstraZeneca logo

AstraZeneca

NASDAQ:AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Cosmos Health logo

Cosmos Health

NASDAQ:COSM
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
GameStop logo

GameStop

NYSE:GME
GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It also sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.
GSK logo

GSK

NYSE:GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.